US Patent Issued to ONCOCROSS on Feb. 3 for "Composition for inhibiting cancer metastasis and treating cancer" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,297, issued on Feb. 3, was assigned to ONCOCROSS Co. LTD. (Seoul, South Korea).

"Composition for inhibiting cancer metastasis and treating cancer" was invented by Yi Rang Kim (Sejong, South Korea), Sang Yun Park (Seoul, South Korea), Ga Eul Yang (Gyeonggi-do, South Korea) and Seung Jun Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an effect of inhibiting cancer metastasis by treatment of chlorphenesin and hydroxychloroquine alone or in combination. Chlorphenesin or hydroxychloroquine has the effect of inhibiting the metastasis and invasion of cancer cells. In particular, since it was identifi...